Aging researcher calls new AI clinical-trials paper 'most important of my life', unveils it in Paris
AllThingsApx · x · 2026-09-07
The researcher behind the biogerontology account announced publication of what he calls the most important paper of his career, focused on how AI should reshape the way clinical trials are conducted. He will present it for the first time at the Nature AI Healthcare event in Paris and promises a longer write-up on the story and its broader implications for trial methodology. Details remain unreleased pending the talk.
More from Research
- Proto-tools, a universal infrastructure layer for generative biology, now open source — jmschreiber91 · 2026-10-26
- New paper finds AI agents negotiate badly under uncertainty and break deals on purpose — xuanalogue · 2026-10-26
- MCP fault injection study: agent task scores drop 60% under realistic tool failures, scale doesn't help — dair_ai · 2026-10-26
- Study: AI reviewing AI misses most reward hacking; best models miss 25%+ of hacks — ronbodkin · 2026-10-26
- FLUX.3 Klein step-distilled to 4-8 steps with CFG baked in — Fit-Structure-6489 · 2026-10-26
- NLI alone rejects 5/6 new agent memories; a 0.45 similarity gate fixes it all — Alternative_Pin9598 · 2026-10-26